Novavax Asks FDA To Authorize Its Non-mRNA Covid Vaccine Novavax’s coronavirus vaccine relies on traditional protein-based technology rather than newer mRNA technology, and was extremely effective at preventing serious Covid-19 symptoms in clinical trials.